Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirokazu Abe

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Urology Journal|March 12, 2023
Upfront Androgen Receptor-Axis-Targeted Therapies in Men with De Novo High-Volume Metastatic Hormone-Sensitive Prostate CancerNatsuo Kimura, Yuki Kaneko, Takahiko Tetsuka, et al.
IJU Case Reports|August 4, 2020
Living-donor kidney transplantation in an end-stage renal disease patient with situs inversus totalis: Three case reportsAtsuhiko Ochi, Kohei Unagami, Takafumi Akanuma, et al.
IJU Case Reports|August 4, 2020
Two-step technique of early adrenal artery ligation in open adrenalectomy of giant right adrenal pheochromocytomas: Three case reportsAtsuhiko Ochi, Bo Fan, Natsuo Kimura, et al.
Clinical Genitourinary Cancer|October 22, 2019
Effectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non-muscle-invasive Bladder Cancer: A Propensity Score-matched AnalysisWataru Fukuokaya, Takahiro Kimura, Jun Miki, et al.
Urologic Oncology|March 19, 2020
Red cell distribution width predicts time to recurrence in patients with primary non-muscle-invasive bladder cancer and improves the accuracy of the EORTC scoring systemWataru Fukuokaya, Takahiro Kimura, Jun Miki, et al.
BMC Women'S Health|May 13, 2022
Novel insight into the correlation between hernia orifice of cystocele and lower urinary tract function: a pilot studyTakeya Kitta, Hirokazu Abe, Huang Ting-Wen, et al.
International Journal of Oncology|April 30, 2013
Effect of a novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen)Haruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2021
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinomaWataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2022
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinomaWataru Fukuokaya, Takafumi Yanagisawa, Masaki Hashimoto, et al.
BJU International|July 15, 2020
Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumabWataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Urology Journal|March 12, 2023
Upfront Androgen Receptor-Axis-Targeted Therapies in Men with De Novo High-Volume Metastatic Hormone-Sensitive Prostate CancerNatsuo Kimura, Yuki Kaneko, Takahiko Tetsuka, et al.
IJU Case Reports|August 4, 2020
Living-donor kidney transplantation in an end-stage renal disease patient with situs inversus totalis: Three case reportsAtsuhiko Ochi, Kohei Unagami, Takafumi Akanuma, et al.
IJU Case Reports|August 4, 2020
Two-step technique of early adrenal artery ligation in open adrenalectomy of giant right adrenal pheochromocytomas: Three case reportsAtsuhiko Ochi, Bo Fan, Natsuo Kimura, et al.
Clinical Genitourinary Cancer|October 22, 2019
Effectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non-muscle-invasive Bladder Cancer: A Propensity Score-matched AnalysisWataru Fukuokaya, Takahiro Kimura, Jun Miki, et al.
Urologic Oncology|March 19, 2020
Red cell distribution width predicts time to recurrence in patients with primary non-muscle-invasive bladder cancer and improves the accuracy of the EORTC scoring systemWataru Fukuokaya, Takahiro Kimura, Jun Miki, et al.
BMC Women'S Health|May 13, 2022
Novel insight into the correlation between hernia orifice of cystocele and lower urinary tract function: a pilot studyTakeya Kitta, Hirokazu Abe, Huang Ting-Wen, et al.
International Journal of Oncology|April 30, 2013
Effect of a novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen)Haruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2021
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinomaWataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2022
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinomaWataru Fukuokaya, Takafumi Yanagisawa, Masaki Hashimoto, et al.
BJU International|July 15, 2020
Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumabWataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa, et al.
Pageof 8